However, a consensus is emerging that estrogen replacement may be beneficial for β-cell insulin secretion, glucose effectiveness, and insulin sensitivity, decreasing the risk of type 2 diabetes [56]. The gene discussed is INS; the disease is type 2 diabetes mellitus.